Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 5

Therapeutics and Clinical Risk Management


Archive: Volume 3, 2007


Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients

Hanne H Villesen, Anne-Marie Banning, Rasmus H Petersen, Sebatian Weinelt, Jesper B Poulsen, et al

Therapeutics and Clinical Risk Management 2007, 3:961-967

Published Date: 15 November 2007

Targeting CD22 as a strategy for treating systemic autoimmune diseases

Thomas Dörner, David M Goldenberg

Therapeutics and Clinical Risk Management 2007, 3:953-959

Published Date: 15 November 2007

Pharmacological causes of hyperprolactinemia

Daria La Torre, Alberto Falorni

Therapeutics and Clinical Risk Management 2007, 3:929-951

Published Date: 15 November 2007

Use of zoledronic acid in the treatment of Paget’s disease

Margaret Seton, Stephen M Krane

Therapeutics and Clinical Risk Management 2007, 3:913-918

Published Date: 15 November 2007

A systematic review of infliximab in the treatment of early rheumatoid arthritis

Sophie Martin Du Pan, Cem Gabay, Axel Finckh

Therapeutics and Clinical Risk Management 2007, 3:905-911

Published Date: 15 November 2007

The role of mesalamine in the treatment of ulcerative colitis

Raffi Karagozian, Robert Burakoff

Therapeutics and Clinical Risk Management 2007, 3:893-903

Published Date: 15 November 2007

Satraplatin in the treatment of hormone-refractory metastatic prostate cancer

Andrew J Armstrong, Daniel J George

Therapeutics and Clinical Risk Management 2007, 3:877-883

Published Date: 15 November 2007

Chronic non-cancer pain: Focus on once-daily tramadol formulations

Flaminia Coluzzi, Consalvo Mattia

Therapeutics and Clinical Risk Management 2007, 3:819-829

Published Date: 15 November 2007

Clinical and molecular aspects of glucocorticoid resistant asthma

Chris J Corrigan, Tuck-Kay Loke

Therapeutics and Clinical Risk Management 2007, 3:771-787

Published Date: 15 November 2007

A critical analysis of barriers to the clinical implementation of pharmacogenomics

Ross A McKinnon, Michael B Ward, Michael J Sorich

Therapeutics and Clinical Risk Management 2007, 3:751-759

Published Date: 15 November 2007

The use of dorzolamide versus other hypotensive agents to prevent glaucomatous progression

Savvas Diafas, Douglas G Day, Jeanette A Stewart, William C Stewart

Therapeutics and Clinical Risk Management 2007, 3:725-732

Published Date: 15 November 2007

Interstitial chemotherapy with biodegradable BCNU (Gliadel®) wafers in the treatment of malignant gliomas

Daniela A Bota, Annick Desjardins, Jennifer A Quinn, Mary L Affronti, Henry S Friedman

Therapeutics and Clinical Risk Management 2007, 3:707-715

Published Date: 15 November 2007

Editorial Foreword || FREE PAPER ||

Garry M Walsh

Therapeutics and Clinical Risk Management 2007, 3:705-706

Published Date: 15 November 2007